Sellas Life Sciences Group (ehemals Galena Biopharma) (Seite 214)

[Earthfire]

von heute :


Galena Biopharma, Inc. Price Target Update


Galena Biopharma, Inc. (NASDAQ:GALE): 6 Analyst have given the stock of Galena Biopharma, Inc. (NASDAQ:GALE) a near short term price target of $5.83. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $2.14. The higher price target estimate is at $8 while the lower price estimates are fixed at $2.

The short interest information of the company was disclosed in the recent information. The short interest in Galena Biopharma, Inc. (NASDAQ:GALE) has increased from 17,194,940 on January 30,2015 to 17,464,919 on February 13,2015. The change was measured at 269,979 shares or 1.6%. The leftover shorts were 14.5% of the floated shares. The days to cover are 13, given the average daily volume of 1,298,575 shares.

Equity Analysts at the MLV & Co. reiterates the rating on Galena Biopharma, Inc. (NASDAQ:GALE). The brokerage firm has issued a Buy rating on the shares. The Analysts at the ratings agency raises the price target from $3 per share to $5 per share.

Galena Biopharma, Inc. (NASDAQ:GALE) edged up 2.21% or 0.04 points in todays market. With a volume of 1,568,950 shares, the stock ended near the highest point of the day at $1.85. In the range-bound session, the stock hit a high of $1.9 and a low of $1.8. The opening trade was executed at $1.83. The shares had ended the previous session at $1.81. The counter has a 52-week high registered at $4.04 and a 52-week low of $1.43. As per the latest information, the company has a market cap of $225 million with approximately 121,457,000 outstanding shares.



http://www.ashburndaily.com/galena-biopharma-inc-price-targe…

[patg]

Hier der Chart:

[Earthfire]

Antwort auf Beitrag Nr.: 49.241.573 von patg am 04.03.15 19:46:44

Zitat von patg: Der Wiederstand den es zu durchbrechen galt lag bei 1,90 $.
Der nächste Wiederstand liegt bei 2,10$

Support/Resistance
Type Value Conf.
resist. 2.30 2
resist. 2.24 2
resist. 2.08 2
resist. 1.99 3
resist. 1.89 5
supp 1.77 17
supp 1.61 13
supp 1.48 4

Read more at http://www.stockta.com/cgi-bin/analysis.pl?symb=GALE&cobrand…

nicht ganz.....2,08$

[patg]

Antwort auf Beitrag Nr.: 49.241.216 von patg am 04.03.15 19:19:25

Der Wiederstand den es zu durchbrechen galt lag bei 1,90 $.
Der nächste Wiederstand liegt bei 2,10$

[patg]

hast recht....

[franke96]

Hätte nichts dagegen,
aber erst mal die 2 heute halten, das würde mir schon reichen.

[patg]

Wir haben die 2 $ geknackt

Kursziel 7$

n.m.M.

[Growth2012]

Antwort auf Beitrag Nr.: 49.240.433 von franke96 am 04.03.15 18:19:04

PORTLAND, Ore., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that the Company will report its fourth quarter and year end 2014 financial results on Thursday, March 5, 2015 after the close of the financial markets. The company will host a conference call following the announcement at 2:00 p.m. P.T./5:00 pm E.T. to discuss the financial and business results

[franke96]

Weiß jemand wann morgen die Zahlen veröffentlicht werden?

[Growth2012]

Antwort auf Beitrag Nr.: 49.239.761 von patg am 04.03.15 17:30:00

@ptag, verstehe

Dann schau lieber hier drauf, ein "W" (wie Winner) offentsichtlich schwer im kommen ...





Falls Schwarz Wort hält & die voran gekündigte Zahlen von Januar tatsächlich liefert, dann sage ich nur folgendes dazu:- "Dat wird, dat wird"